valcyte医保报销多少？

Valcyte is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS), and valcyte is indicated for the prevention of CMV infection in high-risk solid organ transplant patients. Valcyte is the L-valyl ester (prodrug) of ganciclovir, which is rapidly converted into ganciclovir by esterases in the small intestine and liver after oral administration.

Cytomegalovirus infection is a common complication after organ transplantation, with an incidence rate as high as 50%. The pain caused by organ rejection, cardiovascular disease, post-transplantation diabetes and related treatments has seriously affected the quality of life of patients. Valcyte is an oral anti-cytomegalovirus infection drug that combines the advantages of oral administration and intravenous injection. Only taking 2 tablets of valcyte per day can effectively prevent and treat cytomegalovirus infection, avoid the direct and indirect harm caused by cytomegalovirus infection, and significantly improve the patient's quality of life and long-term survival rate.

Valcyte is an oral medication and should be taken with food. The recommended dose for induction treatment of CMV retinitis in adults is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity. After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) once daily. Induction therapy may be repeated in patients with worsening retinitis. So has valcyte been included in the medical insurance? How much can it be reimbursed?

In August 2006, valcyte was launched in China, with a specification of 450mg*60 tablets/box and a price of 16,500$/box. Although valcyte has been on the market in my country for many years, valcyte is not included in medical insurance, which is undoubtedly a huge treatment pressure for patients with average family economic levels. In fact, patients may wish to choose those available in India. The price is relatively high and the price is relatively cheap compared to domestic prices. 450mg*60 tablets cost about RMB 5,500 in Indian pharmacies.